Terms: = Prostate cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Clinical Outcome
3 results:
1. GLUT1 expression in high-risk prostate cancer: correlation with
Meziou S; Ringuette Goulet C; Hovington H; Lefebvre V; Lavallée É; Bergeron M; Brisson H; Champagne A; Neveu B; Lacombe D; Beauregard JM; Buteau FA; Riopel J; Pouliot F
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):441-448. PubMed ID: 31932660
[TBL] [Abstract] [Full Text] [Related]
2. Substratification of high-risk localised prostate cancer treated by radical prostatectomy.
Lodde M; Harel F; Lacombe L; Fradet Y
World J Urol; 2008 Jun; 26(3):225-9. PubMed ID: 18369635
[TBL] [Abstract] [Full Text] [Related]
3. Is transurethral vaporesection of the prostate better than standard transurethral resection?
Helke C; Manseck A; Hakenberg OW; Wirth MP
Eur Urol; 2001 May; 39(5):551-7. PubMed ID: 11464036
[TBL] [Abstract] [Full Text] [Related]
